<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The molecular mechanisms involved in histologic transformation of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) and B-<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (B-CLL) to diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) are <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> and largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Here we explored whether aberrant somatic hypermutation, leading to the acquisition of new mutations in PIM-1, PAX-5, RhoH/<z:chebi fb="6" ids="52444">TTF</z:chebi> and c-MYC genes, is involved in transformation from FL or B-CLL to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Eighteen sequential pairs of FL/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (n=9) and B-CLL/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (n=9) were investigated </plain></SENT>
<SENT sid="3" pm="."><plain>Our findings demonstrate that acquisition of novel mutations due to aberrant somatic hypermutation was associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> transformation in 5/9 (55.5%) cases of FL and 2/9 (22.2%) cases of B-CLL </plain></SENT>
</text></document>